Introduction
============

The use of healthcare resources among geriatric population is tremendously high because the number of patients aged \>65 years is unprecedentedly increasing all over the globe.[@b1-cia-13-1485],[@b2-cia-13-1485] Improving and maintaining the functional status are the cornerstone of geriatric pharma-cotherapy, which can cure or palliate disease as well as enhance health-related quality of life. The rise in the number of comorbidities, polypharmacy, and age-related physiological changes (hepatic and nephrotic functioning, mental status, efficiency of heart, narrowing of vessels, fragility of bones, and weakness of body) alter the pharmacodynamics and pharmacokinetics of drugs due to which geriatrics are more susceptible of developing adverse drug events (ADEs).[@b3-cia-13-1485]--[@b9-cia-13-1485] Therefore, the risk of an unexpected admission for managing health-related issues (eg, severe disease and treatment-related event) that cannot be controlled in the outpatient setting has dramatically increased, and it is named as "unplanned hospitalization".[@b10-cia-13-1485]

The term potentially inappropriate medications (PIMs) encompasses the use of such therapeutic agents whose risk may outweigh their potential benefits, especially when more efficacious pharmacological alternatives are available. A prospective study conducted in India revealed that nearly one-third of the geriatric population was prescribed with at least one PIM.[@b11-cia-13-1485] Similarly, a study conducted in New Zealand suggested that PIMs were utilized by 42.7% of the community-dwelling elderly patients.[@b12-cia-13-1485] Thus, such practices may increase the risk of developing ADEs up to several folds.[@b13-cia-13-1485] This problem has threatened the geriatric population all over the world. For instance, every year 1 million older adults associated with potential ADEs are hospitalized in the USA.[@b14-cia-13-1485],[@b15-cia-13-1485] Another study also found that those elderly patients who were prescribed with PIMs had experienced hospitalization due to the development of adverse health outcomes.[@b16-cia-13-1485] Similar estimations have been made for senior citizens in Australia where medication-associated unplanned hospitalization annually accounts for 15%--22% of the geriatric patients.[@b17-cia-13-1485] Such circumstances may economically burden the healthcare system. Thus, for ensuring patient's safety, improving the quality of life (QoL), and decreasing the drug-related mortalities and morbidities, the medications included in PIMs must be contraindicated for people of this age group.[@b18-cia-13-1485]--[@b23-cia-13-1485] For this reason, American Geriatric Society has developed guidelines, which are named as Beers Criteria for PIM Use in Older Adults.[@b8-cia-13-1485],[@b24-cia-13-1485]--[@b26-cia-13-1485]

Elderly population is growing at much faster rate. The census conducted between 1990 and 2010 in Pakistan revealed that geriatric population has increased by 75.1%.[@b27-cia-13-1485] In 1998, it was also reported by the WHO that the population aged ≥65 years represents 5.6% of the entire population of Pakistan with a probability increasing to 11% by the year 2025.[@b28-cia-13-1485] In the developing world, a demographic rise in the number of geriatrics and the availability of scarce literature on PIMs indicate a need for studies in this area. These studies provide a landmark for stakeholders in making policies, determining the impact of medicines on community level and prioritizing the medical needs. The previously published studies conducted on different regions of the world have showed the effect of using Beers criteria as a guide demonstrated an increasing trend in the use of PIMs. However, it is still ambiguous that whether the utilization of PIMs listed in Beers criteria can lead to the development of ADEs in the elderly people or not, but in Pakistan, there is a scarcity of available literature on zonal, provincial, and national levels that give an insight about the consumption of PIMs by the geriatric patients. Hence, till date no clear estimation can be drawn about PIM-associated unplanned hospitalization of older adults. The aim of the present study is set to find the prescribing pattern of PIMs listed in Beers criteria among geriatric patients that leads to unplanned hospitalization. Also, the risk factors that influence the prescribing of PIMs among this age group have also been evaluated.

Methods
=======

Study design
------------

A quantitative, observational, cross-sectional, and prospective study was conducted in different hospitals of Lahore, Punjab, Pakistan, to scrutinize the prescribing patterns of PIMs and unplanned hospitalizations among the elderly hospitalized patients.

Study settings
--------------

The healthcare settings were randomly selected. Data were collected between December 1, 2017, and February 28, 2018, according to the objectives of the study. These selected settings were tertiary care public and private hospitals where inpatient healthcare services were provided to the patients aged ≥65 years. These were comparable in terms of staff, services, and availability of formulary medicines; thus, health-care professionals followed the same prescribing practices. Hence, randomly selected patients from these tertiary care hospitals would have minimal chances of significant bias.

Study population and sample size
--------------------------------

According to latest Pakistani census, the total population living in Pakistan is 201,995,540. Lahore is the capital city of Punjab province and the second largest city of Pakistan with an estimated population of 11,126,285 people.[@b29-cia-13-1485] Using the Raosoft sample size calculator,[@b30-cia-13-1485] the minimum obligatory sample size was 385 with 95% CI and 5% margin of error: $$n = \frac{Nx}{((N - 1)E2 + x)}$$where *n* is the population size, *x* is the CI, and *E* is the margin of error. Records of those patients who were aged ≥65 years, chronically ill, and hospitalized for \>7 days were included in the study, whereas the records of all those geriatric patients who were hospitalized on a planned basis for acute illness, exacerbation of chronic diseases or infections, end-stage life-threatening diseases, providing pre- and postsurgery medical care, palliative care, and short-term prognosis, and who had incomplete medical records were excluded.

Data collection
---------------

A data collection form consisting of the following five major parts was designed: 1) demographic characteristics; 2) socioeconomic characteristics; 3) health-related characteristics; 4) clinical indications; and 5) past medication history. SPSS Version 21.0 (IBM Corporation, Armonk, NY, USA) was used for the calculation of reliability coefficients. Internal consistency was measured by Cronbach's *α*, while reproducibility was evaluated by using intraclass correlation for each item in the scales, with acceptable values ≥0.6. The Cronbach's *α* value was 0.74 demonstrating the excellent reliability. A pilot study was undertaken between October and November 2017 for pretesting the study instrument.

Measurements
------------

### Demographic characteristics

The following characteristics were evaluated in the demographic data of selected patients: gender (male/female), age (65--74, 75--84, and ≥84 years), and civil status (single, married, widowed, and divorced).

### Socioeconomic characteristics

The socioeconomic characteristics were education level (illiterate, primary, matriculation, intermediate, and graduate), employment status (employed, unemployed, and retired), annual income (low class, middle class, and upper class), and residence (rural and urban). Those patients who were unemployed but received revenue from their lands, business, or received pensions were considered as employed.

### Health-related characteristics

Prescriptions were used to collect medical data while patients' attendants were consulted for demographic, socioeconomic, and health-related data. Health-related characteristics included following parameters: self-reported health (good, moderate, and poor), health service utilization (normal clinic visit ≤3/year and high clinic visit ≥4/year), health risks (smoking, alcohol consumption, and obesity), and comorbidities (present and absent), which included chronic diseases such as diabetes mellitus, coronary vascular disease, respiratory disorders, gastrointestinal disorders, joint diseases, hypertension, and central nervous system disorders. Body mass index (BMI) was used to determine obesity, and patients were considered as normal (BMI,25 kg/m^2^), over weight (25≤BMI,30 kg/m^2^), or obese (BMI≥30 kg/m^2^).[@b31-cia-13-1485]

### Drug utilization evaluation

After surveying, all the medicines were enlisted on the Performa. Anatomical Therapeutic Chemical classification system was used for the estimation of drug utilization patterns.[@b32-cia-13-1485] The active substances mostly prescribed were classified as low (prescribed to \<10% of selected patients), medium (prescribed to ≥10% of selected patients but \<40%), and high (prescribed to \>40% of selected patients).

### PIMs' evaluation

For examining PIMs, medicines prescribed to the selected patients were evaluated according to the 2015 Beers criteria.[@b33-cia-13-1485] Detection of PIMs was based on past medication history of patients who were hospitalized for \>7 days. All the drugs mentioned in the past medication history were checked for appropriateness with respect to indications and interactions. Disease-dependent PIMs were defined on the basis of International Classification of Diseases, *Ninth Revision, Clinical Modification* (ICD-9-CM) codes.[@b34-cia-13-1485] The expert opinions of physicians and clinical pharmacists were also taken in account before reaching the final decision.

### Unplanned hospitalization evaluation

All those selected cases were referred to as "unplanned hospitalization" in which patients visited the emergency department, but within 24 hours, their clinical sign and symptoms did not show any improvement, and there had been the need of further investigation or treatment that compelled the healthcare professionals to admit them in the inpatient ward directly from the emergency room. Therefore, the profile of all the selected participants was scrutinized to check the clinical presentation and diagnostic tests' results at the time of their visit to the emergency room as well as unplanned admission in the inpatient ward. On the basis of diagnostic findings and the sound clinical judgment of physicians and clinical pharmacists, if the possibility of unplanned hospi-talization due to underlying diseases was ruled out, then the patients were asked to show their all prescriptions and pertinent laboratory test results as well as diagnostic findings 1 month prior to their hospitalization. All the information pertaining to drug utilization before unplanned hospitalization was then confirmed by the patient's attendants. Based on past medical history, any such drug was said to be PIM if it must be contraindicated to the patient according to Beers criteria. In this way, the utilization of any PIM by the patients within 1 month prior to their unplanned hospitalization was checked.

Statistical analysis
--------------------

SPSS (IBM Corporation Released 2012, IBM SPSS Statistics for Windows Version 21.0) and Microsoft Excel (MS Office 2010) were used for data analysis. Descriptive statistics such as frequencies and percentages was used to present the data. Furthermore, logistic regression analysis was performed to evaluate the factors associated with the prescribing pattern of PIMs among geriatric patients. Results were expressed as OR accompanied by 95% CIs, and a *P*-value of \<0.05 was used for statistical significance of differences.

Ethics approval and consent to participate
------------------------------------------

Ethical approval including verbal informed consent process was obtained from Pharmacy Research Ethics Committee at Akhtar Saeed College of Pharmaceutical Sciences, Lahore (reference: 08-2017/PREC, September 22, 2017). Before conducting the study, permission was granted from the hospital administrators. The purpose and protocols of this study were thoroughly explained to every participant, and their verbal consents were obtained. Written consent was not possible for most of the respondents because either they were illiterate or they had problems in reading and/or signing the consent document.

Results
=======

A total of 419 elderly hospitalized patients in government and private hospitals of Lahore were approached and 385 consented patients (response rate=91.8%) were included according to the inclusion and exclusion criteria.

A total of 66.2% (n=255) of the participants were male, and 68.1% (n=262) were aged 65--74 years. Over three quarters (81.0%, n=312) were married, just over one-third (39.0%, n=150) were illiterate, and 31.2% (n=120) were of low annual income. Little over one-half (54.0%, n=208) were employed and 66.0% (n=254) were urban residents. Self-reported health was moderate in 60.0% (n=231), whereas 55.3% (n=213) had attended ≥3 clinic visits in the previous year. A total of 44.7% (n=172) were smokers, and comorbidity was present in over three quarters (76.6%, n=295) of the participants. A total of 60.8% (n=234) were subjected to polypharmacy (5--9 drugs), while 36.4% (n=140) were prescribed with one PIM and just over one-half (56.4%, n=217) were hospitalized due to PIMs ([Table 1](#t1-cia-13-1485){ref-type="table"}).

The most common indications among hospitalized patients were CVS and blood-related disorders (52.9%), respiratory disorders (43.3%), and endocrinology and metabolic disorders (31.4%) ([Table 2](#t2-cia-13-1485){ref-type="table"}).

The most commonly prescribed PIMs were N02BA01 (aspirin, n=125, 32.4%), A02BC01 (omeprazole, n=91, 23.6%), A10AB02 (insulin, n=67, 17.4%), A02BC05 (esomeprazole, n=33, 8.5%), C08CA01 (amlodipine, n=32, 8.3%), and R06AA02 (diphenhydramine, n=23, 5.9%) ([Table 3](#t3-cia-13-1485){ref-type="table"}).

Determinants associated with PIMs and unplanned hospitalization
---------------------------------------------------------------

Logistic regression analysis evaluated the association of both PIMs and unplanned hospitalization with the independent variables of study participants. Results revealed that patients aged 75--84 years had 65.7% less PIMs (OR=0.343, 95% CI=0.156--0.756, *P*-value=0.008) compared with those aged 65--74 years. While examining the association between number of drugs and PIMs, polypharmacy (5--9 drugs) had 2.480 times more PIMs (OR=2.480, 95% CI=1.219--5.048, *P*-value=0.012) as compared with those utilizing ≤4 medicines ([Table 4](#t4-cia-13-1485){ref-type="table"}).

Furthermore, results of logistic regression analysis examined the association between independent variables and unplanned hospitalization revealing that polypharmacy (5--9 drugs) had 2.556 times more hospitalization (OR=2.556, 95% CI=1.579--4.135, *P*-value≤0.001) and excessive polyp-harmacy (≥10 drugs) had 37.828 times more hospitalization (OR=37.828, 95% CI=4.754--300.9, *P*-value≤0.001) compared with those utilizing ≤4 medicines ([Table 5](#t5-cia-13-1485){ref-type="table"}).

Discussion
==========

The findings of this study revealed that prior to unplanned hospitalization, most of the patients were prescribed with PIMs including aspirin, omeprazole, insulin, esomeprazole, amlodipine, and diphenhydramine and had been suffering from disorders of CVS, respiratory system, endocrine system, and metabolic system. Similar results were found from previously published study in Nepal where the cardiovascular drugs (eg, amlodipine) and antihistaminic agents (eg, diphenhydramine) were commonly prescribed to 23.16 and 4.6% of the elderly patients.[@b35-cia-13-1485] A national survey in the USA described that the use of insulin among 206 elderly patients per 100,000 outpatient prescription visits is one of the major reasons for unplanned hospitalization because of its association with hypoglycemic events and seizures.[@b36-cia-13-1485] Another study conducted in Karachi, Pakistan, had declared that at least one PIM was prescribed to 64% of the geriatric population.[@b37-cia-13-1485] It is estimated that antihistaminic agents (eg, diphenhydramine), proton pump inhibitors (eg, omepra-zole and esomeprazole), and analgesics (eg, aspirin and nonsteroidal anti-inflammatory drugs) are more frequently used by elderly people than by any other age groups.[@b38-cia-13-1485]--[@b40-cia-13-1485] This is probably due to the reason that old age people mostly suffer from insomnia, heart burn, acid reflex, headache, muscle pain, and joint pain due to multiple comorbidities and the physicians in developing countries such as Pakistan are usually inefficient in diagnosing the underlying cause.[@b41-cia-13-1485],[@b42-cia-13-1485] Also, there is no clinical guideline available in Pakistan for the diagnosis and management of diseases among geriatric patients. Although many international guidelines such as Beers criteria and STOP/START criteria are available for assisting in the selection of appropriate medication for this high-risk population, unfortunately these guidelines are poorly implemented in public and private healthcare settings of this region.[@b43-cia-13-1485]

Logistic regression analysis was used for establishing statistically significant association of PIMs and unplanned hospitalization with patient-related variables. Findings suggested that advanced age and exposure of patient with large number of medicines were the strong determinants of prescribing PIMs, while unplanned hospitalization was only significantly associated with polypharmacy. The correlation is in line with the study conducted in Brazil and Switzerland where elderly patients receiving polypharmacy are at higher risk of unplanned hospitalization.[@b44-cia-13-1485],[@b45-cia-13-1485] Based on a significant causal association, evidence suggested that the risk of unplanned hospitalization can be reduced up to 6% if PIMs are avoided among geriatric patients.[@b46-cia-13-1485] Another study also demonstrated that elderly patients are more prone toward PIM-associated ADEs because of its significant association with polypharmacy.[@b47-cia-13-1485] The possible explanation is that the multiple comorbidities tend the elderly patients to visit multiple physicians of various specialties and thus are at higher risk of prescribing various medicines especially from the list of Beers criteria.[@b48-cia-13-1485] As the previously published studies,[@b49-cia-13-1485]--[@b51-cia-13-1485] other factors including gender, comorbidities, and health service utilization were not found to be correlated with both PIMs and unplanned hospitalization, whereas some studies showed a significant association of female gender and comorbidities with the PIMs.[@b50-cia-13-1485],[@b52-cia-13-1485],[@b53-cia-13-1485] This is merely because of the fact that comorbidities and gender differences may not only influenced by biological differences, but severity of illness, social norms, cultural heritage, behavioral factors, and physiological dissimilarities have an impact on them.[@b54-cia-13-1485] Moreover, other factors such as education (illiterate and literate), residence, and income levels were not found to be significantly associated with the prescribing practices of PIMs and unplanned hospitalization. Evidence suggested that the patients having low literacy skills and poor financial status are 1.5--3 times more likely to utilize PIMs and undergo unplanned hospitalization,[@b55-cia-13-1485] but no such information was found in this study. Therefore, further studies are required for exploring these factors.

Thus, the rational use of medicines among geriatric patients requires their limited access toward PIMs. A multidisciplinary collaborative approach is needed for defining protocols pertaining to disease management and improving the QoL of elderly patients. As the negligence of PIM-associated health crises and unplanned hospitalization can economically burdened the society and the healthcare system, so it becomes mandatory for policy makers to formulate national action plan and healthcare professionals must implement international treatment guidelines in their routine practice.

Strength and limitations
------------------------

To the best of our knowledge, this is the first study in Pakistan that gives an insight about the utilization of PIMs among elderly patients that lead to unplanned hospitalization. The previously published studies conducted in this region also had considered geriatrics as a risk population for the irrational use of medicines, but the spectrum of their findings was confined to the assessment of utilization pattern of PIMs either during hospitalization or after hospitalization. This study highlights the need of developing standard treatment protocols and implementing systematic drug-monitoring system.

The present study has some limitations. First, this is a cross-sectional study with small sample size and data were collected for short duration of time. Second, the defined daily doses of PIMs could not be calculated. Finally, the appropriateness was checked only for drug indications and interactions, while it was not considered for the duplication and duration of therapy, and directions of taking medicines was not taken into account, so the investigators were unable to evaluate that the hospitalization was the result of inappropriate use of PIMs or just having a report of using a PIM 7 days prior to admission.

Conclusion
==========

The present study concluded that PIMs were commonly uti-lized among geriatric patients. The consumption of aspirin, omeprazole, insulin, and diphenhydramine had caused the unplanned hospitalization of these patients. This might be attributable to the unavailability of national standard treatment protocols and disobedience of international guidelines for elderly patients in Pakistan. The usage of these medicines is highly irrational and significantly associated with the advanced age and polypharmacy, while the age of geriatrics was found to be less likely correlated with unplanned hos-pitalization than the number of exposed medicines. Hence, caution must be exercised in prescribing PIMs listed in Beers criteria to the elderly patients.
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###### 

Characteristics of the participants

  Variables                        Male (n=255), n (%)   Female (n=130), n (%)   Total (N=385), n (%)
  -------------------------------- --------------------- ----------------------- ----------------------
  Age (years)                                                                    
   65--74                          163 (42.3)            99 (25.7)               262 (68.1)
   75--84                          74 (19.2)             27 (7.0)                101 (26.2)
   ≥85                             18 (4.7)              4 (1.0)                 22 (5.7)
  Civil status                                                                   
   Single                          9 (2.3)               1 (0.3)                 10 (2.6)
   Married                         200 (51.9)            112 (29.1)              312 (81)
   Widow                           40 (10.4)             15 (3.9)                55 (14.3)
   Divorced                        6 (1.6)               2 (0.5)                 8 (2.15)
  Education level                                                                
   Primary                         47 (12.2)             16 (4.2)                63 (16.4)
   Matriculation                   84 (21.8)             26 (6.8)                110 (28.6)
   Intermediate                    14 (3.6)              5 (1.3)                 19 (4.9)
   Graduate                        33 (8.6)              10 (2.6)                43 (11.2)
   Illiterate                      77 (20)               73 (19)                 150 (39)
  Employment status                                                              
   Employed                        192 (49.9)            16 (4.2)                208 (54)
   Unemployed                      63 (16.4)             114 (29.6)              177 (46)
  Annual income                                                                  
   Low class                       110 (28.6)            10 (2.6)                120 (31.2)
   Middle class                    60 (15.6)             3 (0.8)                 63 (16.4)
   Upper class                     26 (6.8)              7 (1.8)                 33 (8.6)
  Residence                                                                      
   Rural                           86 (22.3)             45 (11.7)               131 (34)
   Urban                           169 (43.9)            85 (22.1)               254 (66)
  Self-reported health                                                           
   Good                            19 (4.9)              10 (2.6)                29 (7.5)
   Moderate                        151 (39.2)            80 (20.8)               231 (60)
   Poor                            85 (22.1)             40 (10.4)               125 (32.5)
  Health service utilization                                                     
   Normal clinic visit (≤3/year)   117 (30.4)            55 (14.3)               172 (44.7)
   High clinic visit (≥4/year)     138 (35.8)            75 (19.5)               213 (55.3)
  Health risks                                                                   
   Smoking                         163 (42.3)            9 (2.3)                 172 (44.7)
   Alcohol consumption             1 (0.3)               0 (0.0)                 1 (0.3)
   Obesity                         44 (11.4)             50 (13.0)               94 (24.4)
   None                            47 (12.2)             71 (18.4)               118 (30.6)
  Comorbidity                                                                    
   Present                         197 (51.2)            98 (25.5)               295 (76.6)
   Absent                          58 (15.1)             32 (8.3)                90 (23.4)
  Number of drugs                                                                
   ≤4                              76 (19.7)             51 (13.2)               127 (33.0)
   Polypharmacy (5--9)             162 (42.1)            72 (18.7)               234 (60.8)
   Excessive polypharmacy (≥10)    17 (4.4)              7 (1.8)                 24 (6.2)
  Number of PIMs                                                                 
   1                               88 (22.9)             52 (13.5)               140 (36.4)
   2                               90 (23.4)             36 (9.4)                126 (32.7)
   3                               34 (8.8)              20 (5.2)                54 (14.0)
   4                               10 (2.6)              6 (1.6)                 16 (4.2)
   5                               2 (0.5)               2 (0.5)                 4 (1.0)
   6                               1 (0.3)               1 (0.3)                 2 (0.5)
  Unplanned hospitalization                                                      
   No                              110 (28.6)            58 (15.1)               168 (43.6)
   Yes                             145 (37.7)            72 (18.7)               217 (56.4)

**Abbreviation:** PIMs, potentially inappropriate medications.

###### 

Indications associated with elderly hospitalized patients

  Serial number   Indications                             Male (n=255), n (%)   Female (n=130), n (%)   Total (N=385), n (%)
  --------------- --------------------------------------- --------------------- ----------------------- ----------------------
  1               CVS and blood related                   138 (54.1)            66 (50.7)               204 (52.9)
  2               CNS                                     27 (10.5)             15 (11.5)               42 (10.9)
  3               GIT                                     37 (14.5)             25 (19.2)               62 (16.1)
  4               Respiratory                             112 (43.9)            55 (42.3)               167 (43.3)
  5               Kidney                                  18 (7.0)              17 (13.0)               35 (9.09)
  6               Joint and muscles related               16 (6.2)              10 (7.6)                26 (6.7)
  7               Endocrinology and metabolic disorders   76 (29.8)             45 (34.6)               121 (31.4)
  8               Others                                  42 (16.4)             24 (18.4)               66 (17.1)

**Abbreviations:** CVS, cardiovascular system; CNS, central nervous system; GIT, gastrointestinal tract.

###### 

PIMs prescribing pattern among study participants

  Serial number   Medicines            ATC code   Male (n=255), n (%)   Female (n=130), n (%)   Total (N=385), n (%)   Trend
  --------------- -------------------- ---------- --------------------- ----------------------- ---------------------- --------
  1               Aspirin              N02BA01    86 (33.7)             39 (30.0)               125 (32.4)             High
  2               Amlodipine           C08CA01    22 (8.6)              10 (7.6)                32 (8.3)               Medium
  3               Alprazolam           N05BA12    9 (3.52)              6 (4.6)                 15 (3.8)               Low
  4               Atropine             A03BA01    8 (3.1)               6 (4.6)                 14 (3.6)               Low
  5               Amitriptyline        N06AA09    0 (0.0)               0 (0.0)                 0 (0.0)                Low
  6               Aripiprazole         N05AX12    1 (0.3)               0 (0.0)                 1 (0.2)                Low
  7               Chlorphenarimine     R06AB04    2 (0.7)               2 (1.5)                 4 (1.0)                Low
  8               Clonazepam           N03AE01    4 (1.5)               2 (1.5)                 6 (1.5)                Low
  9               Chlorzoxazone        M03BB03    2 (0.7)               0 (0.0)                 2 (0.5)                Low
  10              Caffeine             N06BC01    1 (0.3)               0 (0.0)                 1 (0.2)                Low
  11              Clidinium            A03CA02    0 (0.0)               0 (0.0)                 0 (0.0)                Low
  12              Chlorpromazine       N05AA01    0 (0.0)               2 (1.5)                 2 (0.5)                Low
  13              Diclofenac Sodium    M01AB05    13 (5.0)              9 (6.9)                 22 (5.7)               Medium
  14              Dimenhydrinate       R06AA52    8 (3.1)               4 (3.0)                 12 (3.1)               Low
  15              Digoxin              C01AA05    5 (1.9)               3 (2.3)                 8 (2.0)                Low
  16              Diphenhydramine      R06AA02    21 (8.2)              2 (1.5)                 23 (5.9)               Medium
  17              Diltiazem HCL        C08DB01    4 (1.5)               1 (0.7)                 5 (1.2)                Low
  18              Dexamethasone        R01AD03    7 (2.7)               4 (3.0)                 11 (2.8)               Low
  19              Doxazosin            C02CA04    0 (0.0)               1 (0.7)                 1 (0.2)                Low
  20              Ephedrine            R01AA03    2 (0.7)               0 (0.0)                 2 (0.5)                Low
  21              Esomeprazole         A02BC05    21 (8.2)              12 (9.2)                33 (8.5)               Medium
  22              Famotidine           A02BA03    1 (0.3)               0 (0.0)                 1 (0.2)                Low
  23              Flurbiprofen         R02AX01    1 (0.3)               0 (0.0)                 1 (0.2)                Low
  24              Glimepiride          A10BB12    3 (1.1)               6 (4.6)                 9 (2.3)                Low
  25              Glibenclamide        A10BB01    7 (2.7)               0 (0.0)                 7 (1.8)                Low
  26              Hydrocortisone       D07AA02    16 (6.2)              6 (4.6)                 22 (5.7)               Low
  27              Insulin              A10AB02    43 (16.8)             24 (18.4)               67 (17.4)              High
  28              Ibuprofen            M01AE01    4 (1.5)               0 (0.0)                 4 (1.0)                Low
  29              Ketorolac            M01AB15    1 (0.3)               2 (1.5)                 3 (0.7)                Low
  30              Methylprednisolone   D07AC14    2 (0.7)               1 (0.7)                 3 (0.7)                Low
  31              Metoclopramide       A03FA01    5 (1.9)               2 (1.5)                 7 (1.8)                Low
  32              Maloxicam            M01AC06    0 (0.0)               1 (0.7)                 1 (0.2)                Low
  33              Methocarbamol        M03BA03    0 (0.0)               0 (0.0)                 0 (0.0)                Low
  34              Nifedipine           C08CA05    7 (2.7)               1 (0.7)                 8 (2.0)                Low
  35              Naproxen             M02AA12    3 (1.1)               3 (2.3)                 6 (1.5)                Low
  36              Omeprazole           A02BC01    58 (22.7)             33 (25.3)               91 (23.6)              High
  37              Orphenadrine         N04AB02    10 (3.9)              6 (4.6)                 16 (4.1)               Low
  38              Piroxicam            M01AC01    4 (1.5)               6 (4.6)                 10 (2.5)               Low
  39              Promethazine         R06AD02    1 (0.3)               0 (0.0)                 1 (0.2)                Low
  40              Prednisolone         H02AB06    9 (3.5)               9 (6.9)                 18 (4.6)               Low
  41              Peroxitine           N06AB05    3 (1.1)               1 (0.7)                 4 (1.0)                Low
  42              Pentoprazole         A02BC02    1 (0.3)               2 (1.5)                 3 (0.7)                Low
  43              Ranatidine           A02BA02    12 (4.7)              7 (5.3)                 19 (4.9)               Low
  44              Rabeprazole          A02BC04    4 (1.5)               2 (1.5)                 6 (1.5)                Low
  45              Resperidone          N06AX08    1 (0.3)               1 (0.7)                 2 (0.5)                Low
  46              Tramadol             N02AX02    11 (4.3)              7 (5.3)                 18 (4.6)               Low
  47              Theophylline         R03DA04    8 (3.1)               2 (1.5)                 10 (2.5)               Low

**Abbreviations:** ATC, Anatomical Therapeutic Chemical; PIMs, potentially inappropriate medications.

###### 

Logistic regression analysis of determinants associated with PIMs

  Characteristics                  PIMs, n (%)   OR         95% CI   *P*-value      
  -------------------------------- ------------- ---------- -------- -------------- -----------
  Gender                                                                            
   Male                            225 (58.4)    30 (7.8)   1.0      --             --
   Female                          117 (30.4)    13 (3.4)   0.752    0.254--2.221   0.606
  Age (years)                                                                       
   65--74                          237 (61.6)    25 (6.5)   1.0      --             --
   75--84                          84 (21.8)     17 (4.4)   0.343    0.156--0.756   **0.008**
   ≥84                             21 (5.5)      1 (0.3)    1.013    0.113--9.040   0.991
  Civil status                                                                      
   Single                          10 (2.6)      0 (0.0)    1.0      --             --
   Married                         275 (71.4)    37 (9.6)   0.000    0.000--0.000   0.999
   Widow                           49 (12.7)     6 (1.6)    0.000    0.000--0.000   0.999
   Divorced                        8 (2.1)       0 (0.0)    1.511    0.000--0.000   1.00
  Education level                                                                   
   Primary                         57 (14.8)     6 (1.6)    1.0      --             --
   Matriculation                   91 (23.6)     19 (4.9)   0.432    0.142--1.315   0.140
   Intermediate                    17 (4.4)      2 (0.5)    0.407    0.053--3.130   0.388
   Graduate                        39 (10.1)     4 (1.0)    0.418    0.067--2.597   0.350
   Illiterate                      138 (35.8)    12 (3.1)   0.898    0.280--2.886   0.857
  Employment status                                                                 
   Employed                        182 (47.3)    26 (6.8)   1.0      --             --
   Unemployed                      160 (41.6)    17 (4.4)   1.906    0.666--5.458   0.229
  Annual income                                                                     
   Low class                       254 (66.0)    35 (9.1)   1.0      --             --
   Middle class                    58 (15.1)     5 (1.3)    2.886    0.842--9.888   0.092
   Upper class                     30 (7.8)      3 (0.8)    3.014    0.488--18.62   0.235
  Residence                                                                         
   Rural                           118 (30.6)    13 (3.4)   1.0      --             --
   Urban                           224 (58.2)    30 (7.8)   0.986    0.432--2.253   0.973
  Self-reported health                                                              
   Good                            23 (6.0)      6 (1.6)    1.0      --             --
   Moderate                        204 (53.0)    27 (7.0)   2.030    0.664--6.203   0.214
   Poor                            115 (29.9)    10 (2.6)   2.480    0.650--9.460   0.184
  Health service utilization                                                        
   Normal clinic visit (≤3/year)   151 (39.2)    21 (5.5)   1.0      --             --
   High clinic visit (≥4/year)     191 (49.6)    22 (5.7)   1.064    0.493--2.293   0.875
  Health risks                                                                      
   Smoking                         149 (38.7)    23 (6.0)   1.0      --             --
   Alcohol consumption             1 (0.3)       0 (0.0)    --       --             1.000
   Obesity                         84 (21.8)     10 (2.6)   1.343    0.498--3.624   0.561
   None                            108 (28.1)    10 (2.6)   1.727    0.617--4.834   0.298
  Comorbidity                                                                       
   Present                         266 (69.1)    29 (7.5)   1.0      --             --
   Absent                          76 (19.7)     14 (3.6)   0.699    0.318--1.537   0.374
  Number of drugs                                                                   
   ≤4                              103 (26.8)    24 (6.2)   1.0      --             --
   Polypharmacy (5--9)             215 (55.8)    19 (4.9)   2.480    1.219--5.048   **0.012**
   Excessive polypharmacy (≥10)    24 (6.2)      0 (0.0)    --       --             0.998

**Note:** Bold values show statistical significance of differences.

**Abbreviations:** CI, confidence interval; OR, odd ratio; PIMs, potentially inappropriate medications.

###### 

Logistic regression analysis of determinants associated with unplanned hospitalization

  Characteristics                      Unplanned hospitalization, n (%)   OR           95% CI   *P*-value      
  ------------------------------------ ---------------------------------- ------------ -------- -------------- ------------
  Gender                                                                                                       
   Male                                145 (37.7)                         110 (28.6)   1.0      --             --
   Female                              72 (18.7)                          58 (15.1)    1.022    0.516--2.024   0.950
  Age (years)                                                                                                  
   65--74                              149 (38.7)                         113 (29.4)   1.0      --             --
   75--84                              52 (13.5)                          49 (12.7)    0.636    0.367--1.103   0.107
   ≥84                                 16 (4.2)                           6 (1.6)      1.405    0.468--4.218   0.544
  Civil status                                                                                                 
   Single                              6 (1.6)                            4 (1.0)      1.0      --             --
   Married                             169 (43.9)                         143 (37.1)   0.513    0.126--2.093   0.352
   Widow                               34 (8.8)                           21 (5.5)     0.603    0.133--2.734   0.512
   Divorced                            8 (2.1)                            0 (0.0)      --       --             0.999
  Education level                                                                                              
   Primary                             38 (9.9)                           25 (6.5)     1.0      --             --
   Matriculation                       59 (15.3)                          51 (13.2)    0.775    0.381--1.578   0.482
   Intermediate                        9 (2.3)                            10 (2.6)     0.438    0.122--1.577   0.207
   Graduate                            25 (6.5)                           18 (4.7)     0.984    0.328--2.949   0.976
   Illiterate                          86 (22.3)                          64 (16.6)    0.802    0.403--1.594   0.528
  Employment status                                                                                            
   Employed                            117 (30.4)                         91 (23.6)    1.0      --             --
   Unemployed                          100 (26.0)                         77 (20.0)    1.099    0.561--2.154   0.783
  Annual income                                                                                                
   Low class                           163 (42.3)                         126 (32.7)   1.0      --             --
   Middle class                        38 (9.9)                           25 (6.5)     1.207    0.587--2.485   0.609
   Upper class                         16 (4.2)                           17 (4.4)     0.615    0.199--1.899   0.398
  Residence                                                                                                    
   Rural                               75 (19.5)                          56 (14.5)    1.0      --             --
   Urban                               142 (36.9)                         112 (29.1)   0.751    0.449--1.257   0.277
  Self-reported health                                                                                         
   Good                                17 (4.4)                           12 (3.1)     1.0      --             --
   Moderate                            121 (31.4)                         110 (28.6)   0.620    0.257--1.49    0.287
   Poor                                79 (20.5)                          46 (11.9)    0.672    0.252--1.792   0.427
  Health service utilization                                                                                   
   Normal clinic visit (≤3/year)       90 (23.4)                          82 (21.3)    1.0      --             --
   High clinic visit (≥4/year)         127 (33)                           86 (22.3)    1.260    0.767--2.070   0.362
  Health risks                                                                                                 
   Smoking                             97 (25.2)                          75 (19.5)    1.0      --             --
   Alcohol consumption                 1 (0.3)                            0 (0.0)      --       --             1.000
   Obesity                             55 (14.3)                          39 (10.1)    1.038    0.554--1.947   0.907
   None                                64 (16.6)                          54 (14.0)    0.976    0.521--1.827   0.940
  Comorbidity                                                                                                  
   Present                             177 (46)                           118 (30.6)   1.0      --             --
   Absent                              40 (10.4)                          50 (13.0)    0.707    0.409--1.222   0.215
  Number of drugs                                                                                              
   ≤4                                  49 (12.7)                          78 (20.3)    1.0      --             --
   Polypharmacy (5--9 days)            145 (37.7)                         89 (23.1)    2.556    1.579--4.135   ,**0.001**
   Excessive polypharmacy (≥10 days)   23 (6.0)                           1 (0.3)      37.828   4.754--300.9   ,**0.001**

**Note:** Bold values show statistical significance of differences.

**Abbreviations:** CI, confidence interval; OR, odd ratio.
